Abstract
Singh S, Rushakoff RJ, Neinstein AB. A Case Report of Diabetic Ketoacidosis With Combined Use of a Sodium Glucose Transporter 2 Inhibitor and Hybrid Closed-Loop Insulin Delivery. J Diabetes Sci Technol. 2019;13(3):605-606. doi: 10.1177/1932296819838875
The sentence appearing on page 1 of the article, which was originally published as:
“One year before this event, she was started on empagliflozin (300 mg/day)” stated an incorrect dosing for empagliflozin, the correct dosage should be:
One year before this event, she was started on empagliflozin (10 mg/day).